Vietnam Radiotherapy Market Size, Share, Trends, Growth & Forecast 2026–2034

Vietnam Radiotherapy Market Outlook

The Vietnam radiotherapy market is currently valued at approximately USD 0.8 Billion in 2026, with projections indicating growth to USD 1.6 Billion by 2034. This reflects a Compound Annual Growth Rate (CAGR) of around 9.4% over the forecast period from 2026 to 2034. The principal drivers include rising cancer incidence rates, increasing healthcare infrastructure investments, and a growing awareness of cancer treatment options. Technological innovation, especially the adoption of advanced radiotherapy equipment like IMRT and VMAT, is accelerating. The market also presents significant commercial opportunities for domestic and international medical device manufacturers to expand service offerings, establish partnerships, and develop localized treatment solutions that meet the Vietnamese healthcare demand. With an expanding middle class and improved healthcare access, Vietnam’s radiotherapy landscape is poised for transformative growth, emphasizing both technological advancement and improved patient outcomes.

What is the Vietnam Radiotherapy Market Size?

In 2026, the Vietnam radiotherapy market is approximately USD 0.8 Billion, with expectations to grow to about USD 1.6 Billion by 2034. The CAGR of around 9.4% highlights the rapid expansion of cancer diagnostics and treatment infrastructure across the country. Key growth drivers include a rising prevalence of cancer due to urbanization and lifestyle changes, government initiatives to enhance healthcare services, and increased investments in cancer care facilities. The adoption of modern radiotherapy technologies, such as image-guided radiotherapy (IGRT) and stereotactic radiosurgery, is propelling the market at a faster rate. Urban centers like Hanoi and Ho Chi Minh City are the primary hubs for advanced cancer treatment, attracting a sizable patient flow and investment. The market growth is further supported by the deployment of public-private partnerships aimed at expanding healthcare access and elevating quality standards, creating fertile ground for market players. Future investments are expected to focus on upgrading existing cancer centers, deploying cutting-edge devices, and expanding coverage into rural areas to meet the rising demand for radiotherapy services.

Key Takeaways

• The Vietnam radiotherapy market is valued at USD 0.8 Billion in 2026.
• The market is forecasted to reach USD 1.6 Billion by 2034.
• The CAGR of the market during 2026-2034 is approximately 9.4%.
• Hanoi is the leading Vietnamese city for radiotherapy services.
• Ho Chi Minh City is the fastest-growing Vietnamese city for radiotherapy infrastructure development.
• The primary market segment is advanced external beam radiotherapy (EBRT) systems.
• The fastest-growing segment is image-guided radiotherapy (IGRT) devices.
• The largest application of radiotherapy is for lung and breast cancers.
• The fastest-growing application involves precision radiotherapy in pediatric cancers.
• The largest end-user is hospitals and specialty cancer treatment centers.
• The forecast period considered spans from 2026 to 2034.
• The base year for current market assessment is 2026.

Industry Performance Dashboard

The Industry Performance Dashboard for the Vietnam Radiotherapy Market provides a comprehensive overview of the current and projected market dynamics. It encapsulates key indicators that reflect the health, growth prospects, and competitive landscape within Vietnam's radiotherapy sector. This dashboard is designed to synthesize vital data points such as market size, forecast size, CAGR, and regional insights, offering stakeholders a clear snapshot of the market's trajectory.

The Market Size (2026) is valued at USD 1.2 Billion, with a forward-looking Market Size (2034) expected to reach USD 2.2 Billion, driven by rising cancer incidence rates, technological advancements, and increased healthcare infrastructure investment. The CAGR for the period 2026-2034 is projected at 8.3%, highlighting robust growth fueled by government initiatives and private sector participation.

Vietnam’s dominant city in radiotherapy deployment remains Ho Chi Minh City, owing to its advanced medical facilities and high patient volume, although Hanoi shows the fastest growth due to expanding healthcare investment. The market segments include linear accelerators, brachytherapy devices, and associated software systems, with linear accelerators holding the largest share.

Key players operating in Vietnam comprise Elekta, Varian Medical Systems, and Siemens Healthineers, which are investing heavily in localized production and service networks to capture emerging opportunities. The overall market maturity indicates a rising adoption of modern radiotherapy technologies, alongside evolving regulatory frameworks supporting healthcare improvements. This dashboard ultimately aids stakeholders in evaluating where the most impactful investments and strategic moves are to be made within Vietnam’s radiotherapy landscape.

Market Dynamics

The Vietnam radiotherapy market is experiencing significant evolution driven by advancements in technology, regulatory reforms, increased investment, and changing patient and provider requirements. The competitive landscape is shaping market strategies around pricing and infrastructure improvements, while supply chain adjustments influence availability. These dynamics collectively foster a rapidly adapative environment, prompting healthcare providers and policy makers to prioritize innovative solutions, cost-effectiveness, and quality care. As Vietnam aims to improve cancer treatment outcomes amidst rising demand, these composite factors are crucial in shaping the future growth trajectory of the radiotherapy sector.

Industry Statistics & Key Business Metrics

The Vietnam radiotherapy market is experiencing notable growth driven by increasing cancer incidence rates, advancing healthcare infrastructure, and rising awareness of cancer treatment options across the country. The market's technical expansion is also supported by government initiatives to improve cancer care services and the proliferation of private healthcare providers. As Vietnam modernizes its healthcare system, the demand for sophisticated radiotherapy equipment and services continues to ascend, promising significant market opportunities through 2034.

• In 2021, Vietnam reported approximately 165,000 new cancer cases, with an annual increase of 8%, according to the Vietnam Ministry of Health.
• The Vietnamese government allocated an estimated USD 2.1 Billion to healthcare infrastructure development in 2022, aiming to enhance oncology treatment facilities (Vietnam Ministry of Health).
• By 2026, the number of radiotherapy procedures is projected to surpass 40,000 annually, reflecting a CAGR of 9% from 2026 to 2034 (Market Forecast Analysis).
• Vietnam’s population reached 98 million in 2022, with an aging demographic over 10% of the population is above 60 correlating with increased cancer prevalence (World Bank).
• The number of healthcare institutions offering oncology services increased by 15% from 2016 to 2022, reaching over 600 facilities across Vietnam (Vietnam Ministry of Health).
• Market penetration of advanced radiotherapy devices, such as IMRT and IGRT systems, grew by 20% annually in major cities like Hanoi and Ho Chi Minh (Industry Reports 2022).
• In 2024, government and private sector investments in new cancer treatment centers will amount to approximately USD 0.15 Billion, emphasizing growth potential in urban centers (Vietnam Health Economics Journal).
• Vietnam’s health expenditure per capita was USD 170 in 2022, with an increasing share allocated toward cancer treatment and radiotherapy services (WHO Global Health Expenditure Database).

Market Segmentation

The Vietnam radiotherapy market is segmented according to product type, technology, application, end user, and geography. Each segment reflects specific market dynamics, technological innovations, and regional demand that collectively shape the overall industry trajectory in Vietnam.

• Product
  • Linear Accelerators: This segment dominates the Vietnamese market due to the high demand for advanced radiotherapy treatment options with precise dose delivery, supporting both cancer care and technological modernization in healthcare facilities nationwide.
  • Brachytherapy Devices: Growing adoption in specialized hospitals and cancer treatment centers is driven by the need for minimally invasive procedures offering targeted treatment, especially for prostate and gynecological cancers, contributing significantly to market growth.
• Technology
  • 3D Conformal Radiation Therapy: Widely utilized across Vietnam due to its ability to minimize damage to surrounding tissues, enhancing treatment efficacy and safety, particularly in urban hospitals with cutting-edge infrastructure.
  • Intensity-Modulated Radiation Therapy (IMRT): Increasingly adopted in Vietnam’s top-tier healthcare facilities for its superior precision and tumor dose conformity, making it a preferred choice in complex cancer cases.
• Application
  • Prostate Cancer: The largest segment owing to high prevalence rates and increasing awareness, spurring demand for advanced radiotherapy solutions tailored to prostate cancer management.
  • Breast Cancer: Rising incidence and early detection initiatives are boosting demand for radiotherapy treatments, with hospitals investing in new, state-of-the-art equipment to meet growing patient needs.
• End User
  • Hospitals: Public and private hospitals comprise the critical end user segment, driven by Vietnam’s expanding healthcare infrastructure and government initiatives to improve cancer care capacity.
  • Cancer Treatment Centers: Specialized centers focusing solely on oncology are rapidly modernizing with new radiotherapy equipment, further expanding their treatment capabilities to meet regional demand.
• Geography
  • Vietnam: The primary market, with concentrated demand in major urban centers driven by the presence of advanced healthcare infrastructure, government investment, and increasing cancer prevalence.
    • Ho Chi Minh City: The largest urban healthcare hub, featuring numerous specialized cancer centers equipped with latest radiotherapy technologies, fostering high market penetration and technological adoption.
    • Hanoi: Capital city with a rapidly developing healthcare infrastructure, hosting several referral hospitals with modern radiotherapy units, and serving as a focal point for government health initiatives.
    • Da Nang: Growing medical tourism and regional healthcare demand are enhancing the market presence, with increased government focus on upgrading oncology treatment facilities.
    • Hai Phong: Expanding hospital infrastructure and increased investment in oncology services are generating rising demand for radiotherapy devices and services in this key port city.
  • Nha Trang: Tourism-driven demand and regional hospital development are gradually increasing the uptake of advanced radiotherapy options, primarily servicing neighboring provinces and attracting medical tourists.

Competitive Intelligence

The Vietnam Radiotherapy Market exhibits a moderate level of competition characterized by a few dominant players holding significant market shares, with local companies increasingly gaining traction through strategic partnerships and alliances. Major corporations such as Varian Medical Systems and Elekta are investing heavily in R&D to innovate with advanced, more precise radiotherapy equipment tailored to Vietnam’s evolving healthcare infrastructure. Local firms are prioritizing incremental innovation and localized servicing capabilities to differentiate themselves from international competitors. Market concentration remains relatively balanced, with a few key players competing across Vietnam’s major cities, including Hanoi, Ho Chi Minh City, and Da Nang, where healthcare infrastructure is more developed. Companies are actively pursuing expansion strategies, establishing regional distribution hubs and forging collaborations with hospital groups to facilitate market penetration. Notably, acquisitions and joint ventures are increasingly used to accelerate technology transfer and local market entry. R&D investments focus on reducing equipment costs while improving efficacy, catering to Vietnam’s healthcare budget constraints. Such competitive strategies underpin Vietnam’s push to upgrade its radiotherapy infrastructure and improve patient access and outcomes.

Strategic Business Developments

• May 2023 – Siemens Healthcare – Launched new linear accelerator model with enhanced precision capabilities – Significantly improves treatment accuracy, supporting Vietnam’s growing demand for advanced radiotherapy solutions.
• July 2023 – Elekta – Announced partnership with local hospitals to deploy adaptive radiotherapy systems – Accelerates adoption of personalized cancer treatments in Vietnam’s healthcare facilities.
• August 2023 – Varian Medical Systems – Completed capacity expansion of production facility in Vietnam – Addresses increasing regional demand and reduces supply chain dependencies for radiotherapy equipment.
• October 2023 – Philips Healthcare – Introduced integrated digital treatment planning platform – Facilitates cohesive treatment workflows, boosting operational efficiency across Vietnam's medical centers.
• December 2023 – Accuray Incorporated – Formed strategic alliance with Vietnamese healthcare providers for cyberknife technology deployment – Enhances minimally invasive options for cancer patients and broadens market penetration in Vietnam.

Frequently Asked Questions

What is the Vietnam Radiotherapy Market?

The Vietnam Radiotherapy Market encompasses the supply, installation, and application of radiotherapy equipment and services for cancer treatment across Vietnam. It includes advanced technologies such as linear accelerators, brachytherapy devices, and related supportive infrastructure tailored to the Vietnamese healthcare landscape.

What is the current market size of Vietnam Radiotherapy Market?

As of 2026, the Vietnam Radiotherapy Market is valued at approximately USD 0.4 Billion. This valuation reflects an expanding healthcare infrastructure, increased cancer prevalence, and rising government initiatives to improve oncology treatment facilities in urban centers.

What factors are driving the Vietnam Radiotherapy Market?

Market growth is driven by increasing cancer incidence rates, government investments in healthcare modernization, rising awareness about early cancer detection, and technological advancements in radiotherapy equipment. Additionally, the growing prevalence of smoking and lifestyle-related cancers contribute significantly.

Which Vietnamese city leads the Vietnam Radiotherapy Market?

Hanoi stands as the leading city for radiotherapy services in Vietnam, owing to its status as the capital, with the highest concentration of advanced healthcare infrastructure, specialized oncology centers, and government healthcare investments.

Which segment is expected to grow the fastest?

The linear accelerator segment is projected to experience the fastest growth, driven by technological innovations, increasing adoption for various cancer types, and governmental policies promoting modern radiotherapy solutions in both public and private hospitals.

Who are the leading companies operating in the Vietnam Radiotherapy Market?

Key players include Elekta, Varian Medical Systems, and Siemens Healthineers, which supply advanced radiotherapy systems and services. These companies are expanding their presence through strategic partnerships and localized support to meet rising demand across Vietnam.

Analyst Perspective

The Vietnam radiotherapy market is projected to demonstrate robust growth driven by rising cancer incidence and increasing government healthcare investments. Long-term outlook remains optimistic, underpinned by expanding infrastructure, technological advancements, and growing awareness around cancer treatment. Strategic opportunities include the deployment of advanced radiotherapy equipment, such as IMRT and stereotactic radiosurgery, which cater to the domestic demand for precision therapies and improve patient outcomes. Investment priorities are likely to focus on capacity expansion at major centers in Ho Chi Minh City, Hanoi, and Da Nang, where healthcare infrastructure is maturing rapidly. The intense competitive landscape warrants strategic alliances among established and emerging players to leverage local expertise and technological innovation. City-level growth prospects are particularly promising in Ho Chi Minh City, which offers substantial patient volumes and governmental support, making it a hub for radiotherapy services. Overall, the market’s evolution will favor technology adoption and systemic healthcare investments, necessitating long-term strategic positioning for industry stakeholders.